Antipsychotics

Licensed for schizophrenia (15 - 17 years) and mania ((13 - 17 years)

Depot not licensed in children

Not licensed for use in children but used to treat schizophrenia (12 - 17 years), monotherapy and combination therapy for mania (12 - 17 years)

Not licensed for use in children but used to treat schizophrenia (12 - 17 years), and for mania in bipolar disorder (12 - 17 years)

Not licensed for use in children for psychosis, mania or autism

but used for acute and chronic psychosis (12 - 17 years), short-term monotherapy of mania in bipolar disorder (12 - 17 years), short-term treatment (up to 6 weeks) of persistent aggression in conduct disorder (5 - 17 years) and short-term treatment of severe aggression in autism (5 - 17 years).

Not licenced for use in children but used for acute psychotic episode in schizophrenia and schizophrenia with predominantly negative symptoms (15 - 17 years)

For schizophrenia (13 - 17 years)

Oral for schizophrenia and other psychosis under expert supervision (1 - 17 years)

Intramuscular for relief of acute symptoms of psychosis under expert supervision (1 - 17 years)

For use when alternatives not effective or not tolerated

For schizophrenia (13 - 17 years), persistent, severe aggression in autism or pervasive developmental disorders (6–17 years) and severe tic disorders, including Tourette's syndrome [when educational, psychological and other pharmacological treatments ineffective] (10–17 years)

For schizophrenia (14 - 17 years).

Not licensed for use in Tourette syndrome but used for this indication (2 - 17 years)

Schizophrenia and other psychoses, short-term adjunctive management of psychomotor agitation, excitement, and violent or dangerously impulsive behaviour (12 - 17 years)

Short-term adjunctive management of severe anxiety (3 - 17 years)

Not licensed for use in children under 16 years but used to treat schizophrenia in patients unresponsive to, or intolerant of, conventional antipsychotic drugs